JP2019521182A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019521182A5 JP2019521182A5 JP2019517169A JP2019517169A JP2019521182A5 JP 2019521182 A5 JP2019521182 A5 JP 2019521182A5 JP 2019517169 A JP2019517169 A JP 2019517169A JP 2019517169 A JP2019517169 A JP 2019517169A JP 2019521182 A5 JP2019521182 A5 JP 2019521182A5
- Authority
- JP
- Japan
- Prior art keywords
- enteric
- dry weight
- coated capsule
- capsule according
- oxalate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE1650828-5 | 2016-06-13 | ||
| SE1650828 | 2016-06-13 | ||
| PCT/EP2017/064422 WO2017216165A1 (en) | 2016-06-13 | 2017-06-13 | Compositions and methods for the treatment or prevention of oxalate-related disorders |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2019521182A JP2019521182A (ja) | 2019-07-25 |
| JP2019521182A5 true JP2019521182A5 (https=) | 2020-07-27 |
| JP7016353B2 JP7016353B2 (ja) | 2022-02-04 |
Family
ID=59067657
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019517169A Expired - Fee Related JP7016353B2 (ja) | 2016-06-13 | 2017-06-13 | オキサレート関連障害を処置または防止するための組成物および方法 |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US10765709B2 (https=) |
| EP (1) | EP3468572B1 (https=) |
| JP (1) | JP7016353B2 (https=) |
| CN (1) | CN109641019A (https=) |
| AU (1) | AU2017286220A1 (https=) |
| CA (1) | CA3023042A1 (https=) |
| ES (1) | ES2913398T3 (https=) |
| IL (1) | IL263477A (https=) |
| JO (1) | JOP20180110A1 (https=) |
| MA (1) | MA45226A (https=) |
| TN (1) | TN2018000420A1 (https=) |
| WO (1) | WO2017216165A1 (https=) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3468572B1 (en) * | 2016-06-13 | 2022-03-02 | OxThera Intellectual Property AB | Compositions and methods for the treatment or prevention of oxalate-related disorders |
| US20210386793A1 (en) * | 2018-10-04 | 2021-12-16 | Oxthera Intellectual Property Ab | New medical use of oxalate-reducing bacteria |
| CN110607262B (zh) * | 2019-09-25 | 2022-03-25 | 君维安(武汉)生命科技有限公司 | 一种干预炎性肠炎的益生菌组合物及其筛选方法和应用 |
| EP3839039A1 (en) * | 2019-12-16 | 2021-06-23 | 4D Pharma Research Limited | Providing bacterial biomass with improved storage stability |
| BR112022013867A2 (pt) * | 2020-01-14 | 2022-09-13 | Synlogic Operating Co Inc | Bactérias manipuladas para tratar distúrbios nos quais o oxalato é prejudicial |
| CA3175041A1 (en) * | 2020-03-10 | 2021-09-16 | Federation Bio Inc. | Microbial consortia for the treatment of disease |
| EP4043018A1 (en) * | 2021-02-10 | 2022-08-17 | Charité - Universitätsmedizin Berlin | Composition and method for reducing oxalate levels in patients receiving maintenance dialysis |
| CA3216136A1 (en) * | 2021-04-30 | 2022-11-03 | Aaron Blake Cowley | Compositions for preserving anaerobic microorganisms and methods of making and using the same |
| WO2023102091A2 (en) * | 2021-12-01 | 2023-06-08 | Federation Bio, Inc. | Microbial consortia |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5286495A (en) * | 1992-05-11 | 1994-02-15 | University Of Florida | Process for microencapsulating cells |
| BG61712B1 (bg) * | 1994-12-29 | 1998-04-30 | "Ел Би Булгарикум" ЕАД | закваски за българско кисело мляко и млечнокисели продукти и методи за получаването им |
| US6355242B1 (en) | 1997-05-23 | 2002-03-12 | Ixion Biotechnology, Inc. | Materials and methods for treating or preventing oxalate-related disease |
| US8486389B2 (en) * | 1997-05-23 | 2013-07-16 | Oxthera, Inc. | Compositions and methods for treating or preventing oxalate-related disease |
| JP4996780B2 (ja) | 1997-05-23 | 2012-08-08 | オクセラ インコーポレイテッド | シュウ酸塩関連疾患を予防するためのシュウ酸塩分解微生物またはシュウ酸塩分解酵素 |
| WO2005097176A2 (en) | 2004-03-26 | 2005-10-20 | University Of Florida Research Foundation, Inc. | Modulating oxalate transport |
| CA2608862C (en) | 2004-06-11 | 2020-05-05 | Trustees Of Tufts College | Silk-based drug delivery system |
| WO2007070052A2 (en) | 2005-12-14 | 2007-06-21 | Oxthera, Inc. | Pharmaceutical compositions and methods for treating or preventing oxalate-related disease |
| JP5558002B2 (ja) | 2005-12-16 | 2014-07-23 | オクセラ インコーポレイテッド | シュウ酸塩低減化のための組成物および方法 |
| JP5193626B2 (ja) | 2008-02-20 | 2013-05-08 | 日本曹達株式会社 | 微生物農薬製剤の保存方法 |
| US9714456B2 (en) | 2013-01-18 | 2017-07-25 | Allena Pharmaceuticals, Inc. | Crystallized oxalate decarboxylase and methods of use |
| EP3468572B1 (en) * | 2016-06-13 | 2022-03-02 | OxThera Intellectual Property AB | Compositions and methods for the treatment or prevention of oxalate-related disorders |
-
2017
- 2017-06-13 EP EP17730457.3A patent/EP3468572B1/en not_active Not-in-force
- 2017-06-13 JP JP2019517169A patent/JP7016353B2/ja not_active Expired - Fee Related
- 2017-06-13 CA CA3023042A patent/CA3023042A1/en not_active Abandoned
- 2017-06-13 CN CN201780036943.1A patent/CN109641019A/zh active Pending
- 2017-06-13 AU AU2017286220A patent/AU2017286220A1/en not_active Abandoned
- 2017-06-13 ES ES17730457T patent/ES2913398T3/es active Active
- 2017-06-13 MA MA045226A patent/MA45226A/fr unknown
- 2017-06-13 TN TNP/2018/000420A patent/TN2018000420A1/en unknown
- 2017-06-13 WO PCT/EP2017/064422 patent/WO2017216165A1/en not_active Ceased
- 2017-06-13 US US16/308,439 patent/US10765709B2/en not_active Expired - Fee Related
-
2018
- 2018-12-04 IL IL263477A patent/IL263477A/en unknown
- 2018-12-05 JO JOP/2018/0110A patent/JOP20180110A1/ar unknown
-
2020
- 2020-09-02 US US17/010,570 patent/US20210052670A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2019521182A5 (https=) | ||
| US10765709B2 (en) | Compositions and methods for the treatment or prevention of oxalate-related disorders | |
| US10758561B2 (en) | Composition based on xyloglucan and proteins for the treatment of intestinal disorders | |
| JP3633936B2 (ja) | センナ剤形 | |
| JP2020527580A5 (https=) | ||
| BR112019016705A2 (pt) | composições e métodos para tratar doença associada à permeabilidade do epitélio intestinal | |
| MD3684344T2 (ro) | Comprimate de deferipronă cu eliberare întârziată și metode de utilizare a acestora | |
| JP2017515888A (ja) | 自己消化の治療用組成物 | |
| JP5850518B2 (ja) | 高分子化環状ニトロキシドラジカル化合物の潰瘍性消化管の炎症の処置剤 | |
| FI3706724T3 (fi) | Suun kautta otettavia rifamysiini sv -koostumuksia | |
| Chan et al. | Short bowel syndrome in adults—part 4-A. A guide to front line drugs used in the treatment of short bowel syndrome | |
| US12569475B2 (en) | Method for eradicating helicobacter pylori infection in patients regardless of body mass index | |
| CN105073104A (zh) | 卡巴他赛及其治疗转移性前列腺癌的用途 | |
| Manz et al. | Treatment algorithm for moderate to severe ulcerative colitis. | |
| RU2812928C2 (ru) | Твердая композиция для доставки | |
| US20210386793A1 (en) | New medical use of oxalate-reducing bacteria | |
| ZA200500064B (en) | Combination of an allosteric inhibitor or matrix metalloproteinase-13 with a selective inhibitor of cyclooxygenase-2 that is not celecoxib or valdecoxib. | |
| Reckitt Benckiser | The effectiveness of alginate therapy in managing gord | |
| JP5626698B1 (ja) | カルシウム低吸収型経口リン吸着剤 | |
| Özgüney | Conventional and novel pharmaceutical dosage forms on prevention of gastric ulcers | |
| HK40094222A (zh) | 预防、治疗或改善溃疡性结肠炎的阿米莫德 | |
| KR20250151351A (ko) | 변형-방출형 알기네이트-기반 조성물 | |
| CA3260258A1 (en) | PHARMACEUTICAL DOSAGE FORM FOR ORAL ADMINISTRATION CONTAINING LANTHAN AND ITS USE IN A METHOD OF TREATMENT OF HYPEROXALURIA | |
| WO2009120054A1 (es) | Metoclopramida de liberación prolongada de 24 horas | |
| CN111617065A (zh) | 普伐他汀钠在制备治疗新冠肺炎药物中的应用 |